Stryker Sustainability Solutions has been the subject of 27 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Hubei JXBio Pharmaceutical Co., Ltd..
Hubei JXBio Pharmaceutical Co., Ltd.: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.
Stryker Sustainability Solutions: 0 warning letters, 27 recalls, 0 approval records, 0 Form 483s.
Side by side
Hubei JXBio Pharmaceutical Co., Ltd. — Warning letters0
Stryker Sustainability Solutions — Warning letters0
Hubei JXBio Pharmaceutical Co., Ltd. — Recalls0
Stryker Sustainability Solutions — Recalls27
Hubei JXBio Pharmaceutical Co., Ltd. — Approval records0
Stryker Sustainability Solutions — Approval records0
Hubei JXBio Pharmaceutical Co., Ltd. — Form 483s1
Stryker Sustainability Solutions — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Hubei JXBio Pharmaceutical Co., Ltd. vs Stryker Sustainability Solutions: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/hubei-jxbio-pharmaceutical-co-ltd-vs-stryker-sustainability-solutions
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗